1,387 results on '"Boccadoro M"'
Search Results
2. About a new method to enhance the productivity of die sinking EDM
3. Multiple myeloma: EHA-ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up†
4. Using recycled material to produce gas-atomized metal powders for additive manufacturing processes
5. Real-Time Wire EDM Tool Simulation Enabled by Discharge Location Tracker
6. Towards a better controlled EDM: industrial applications of a discharge location sensor in an industrial wire electrical discharge machine.
7. CO169 Pan-Stakeholder Core Outcome Set (COS) Definition for Hematological Malignancies in the Framework of the EU Project, Harmony: the Healthcare Alliance for Resourceful Medicine Offensive Against Neoplasms in Hematology
8. Increasing the Injection Moulding Productivity through EDM Surface Modulation
9. Expert Panel Consensus Statement for Proper Evaluation of First Relapse in Multiple Myeloma
10. Investigation on the effect of the gas-to-metal ratio on powder properties and PBF-LB/M processability
11. P23 EMAGINE/CARTITUDE-6: A RANDOMIZED PHASE 3 STUDY OF DVRD FOLLOWED BY CILTACABTAGENE AUTOLEUCEL VERSUS DVRD FOLLOWED BY AUTOLOGOUS STEM CELL TRANSPLANT IN TRANSPLANT-ELIGIBLE PATIENTS WITH NEWLY DIAGNOSED MULTIPLE MYELOMA
12. B02 CARFILZOMIB AND LENALIDOMIDE-BASED THERAPY FOR THE TREATMENT OF PRIMARY PLASMA CELL LEUKEMIA: RESULTS OF THE FINAL ANALYSIS OF THE PROSPECTIVE PHASE 2 EMN12/HOVON-129 STUDY FOR PATIENTS AGED 18-65 YEARS
13. P36 BELANTAMAB MAFODOTIN IN PATIENTS WITH RELAPSED AND REFRACTORY MULTIPLE MYELOMA WHO HAVE RECEIVED AT LEAST ONE PROTEASOME INHIBITOR, ONE IMMUNOMODULATORY AGENT AND ONE ANTI-CD38 MONOCLONAL ANTIBODY: A RETRO-PROSPECTIVE ITALIAN OBSERVATIONAL STUDY
14. B03 CARFILZOMIB AND LENALIDOMIDE FOR PRIMARY PLASMA CELL LEUKEMIA: FINAL RESULTS OF THE PROSPECTIVE PHASE 2 EMN12/HOVON-129 STUDY FOR PATIENTS AGED ≥66 YEARS
15. P39 DEDALO: PHASE II STUDY OF DARATUMUMAB PLUS POMALIDOMIDE AND DEXAMETHASONE (DPD) IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA AND 17P DELETION
16. P07 BORTEZOMIB-MELPHALAN-PREDNISONE (VMP) VS. LENALIDOMIDE-DEXAMETHASONE (RD) IN REAL-LIFE MULTIPLE MYELOMA PATIENTS INELIGIBLE FOR TRANSPLANT: UPDATED ANALYSIS OF THE RANDOMIZED PHASE IV REAL MM TRIAL
17. EDM Drilling and Shaping of Cooling Holes in Inconel 718 Turbine Blades
18. Experimental Study of EDM-Drilling and Shaping of SiSiC and SiC
19. Performance and Limitations of the Conventional Electrode Materials for Erosion of High Aspect Ratio Microcavities
20. A strategy for low electrode wear in meso–micro-EDM
21. Electrode wear protection mechanism in meso–micro-EDM
22. Differences among young adults, adults and elderly chronic myeloid leukemia patients
23. Autologous transplant vs oral chemotherapy and lenalidomide in newly diagnosed young myeloma patients: a pooled analysis
24. Long-term follow-up of allogeneic stem cell transplantation in relapsed/refractory Hodgkin lymphoma
25. Corrigendum to “Corrigendum to ‘Multiple myeloma: EHA-ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up’”
26. A phase 2 study of three low-dose intensity subcutaneous bortezomib regimens in elderly frail patients with untreated multiple myeloma
27. Prospective molecular monitoring of minimal residual disease after non-myeloablative allografting in newly diagnosed multiple myeloma
28. S300: HEALTH-RELATED QUALITY OF LIFE IN TRANSPLANT-INELIGIBLE REAL-LIFE MULTIPLE MYELOMA PATIENTS TREATED WITH BORTEZOMIB-MELPHALAN-PREDNISONE (VMP) VS. LENALIDOMIDE-DEXAMETHASONE (RD)
29. P932: ON-DEMAND PLERIXAFOR WITH CYCLOPHOSPHAMIDE AND G-CSF FOR HEMATOPOIETIC STEM-CELL MOBILIZATION IN MULTIPLE MYELOMA PATIENTS: FINAL RESULTS OF THE MOZOBL06877 STUDY
30. PB1984: ELOTUZUMAB PLUS LENALIDOMIDE AND DEXAMETHASONE IN RELAPSED/REFRACTORY MULTIPLE MYELOMA: EXTENDED 3-YEAR FOLLOW-UP OF AN ITALIAN, MULTICENTER, EXPERIENCE OUTSIDE OF CONTROLLED CLINICAL TRIALS
31. Super-finished Surfaces using Meso-micro EDM
32. Carfilzomib, Pomalidomide, and Dexamethasone As Second-line Therapy for Lenalidomide-refractory Multiple Myeloma
33. Successful mobilization of PBSCs predicts favorable outcomes in multiple myeloma patients treated with novel agents and autologous transplantation
34. Clinical impact of immunophenotypic remission after allogeneic hematopoietic cell transplantation in multiple myeloma
35. Long-term results of the GIMEMA VEL-03-096 trial in MM patients receiving VTD consolidation after ASCT: MRD kinetics' impact on survival
36. Die-sink EDM in Meso-Micro Machining
37. COVID-19 AND MYELOMA
38. Multiple myeloma: EHA-ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up (vol 32, pg 309, 2021)
39. Corrigendum to ‘Multiple myeloma: EHA-ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up’
40. Circulating miRNA markers show promise as new prognosticators for multiple myeloma
41. Next-generation sequencing and real-time quantitative PCR for minimal residual disease detection in B-cell disorders
42. Lenalidomide and low-dose dexamethasone for newly diagnosed primary plasma cell leukemia
43. Special wire guide for on-machine wire electrical discharge dressing of metal bonded grinding wheels
44. The use of bisphosphonates in multiple myeloma: recommendations of an expert panel on behalf of the European Myeloma Network
45. Differences among young adults, adults and elderly chronic myeloid leukemia patients
46. Reduced Tumor Growth after Low-Dose Irradiation or Immunization against Blastic Suppressor T Cells
47. Lenalidomide−prednisone induction followed by lenalidomide−melphalan−prednisone consolidation and lenalidomide−prednisone maintenance in newly diagnosed elderly unfit myeloma patients
48. APOLLO: Phase 3 randomized study of subcutaneous Daratumumab plus Pomalidomide and Dexamethasone (D-Pd) versus Pomalidomide and Dexamethasone (Pd) alone in patients with Relapsed/Refractory Multiple Myeloma (RRMM)
49. Ixazomib-lenalidomide-dexamethasone in routine clinical practice: Effectiveness in relapsed/refractory multiple myeloma
50. Recommendations for vaccination in multiple myeloma: a consensus of the European Myeloma Network
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.